XLI has given back 1.1% on the week to close at $183.57, but the more interesting story is what's happening beneath the surface — short positioning has plateaued after its post-August-7 rebuild, while options traders have quietly stepped back from the defensive stance that dominated July.
The short rebuild flagged in the August 12 note has lost momentum. From the trough of 17.6 million shares on August 7, shorts climbed to 19.1 million by August 11 — a sharp four-day reversal. Since then, the position has largely stalled, oscillating between 18.3 million and 18.9 million shares over the past week, settling at 18.8 million as of August 18. At 12.3% of free float, that's still below the mid-July peak above 13% but meaningfully above the early-August lows. The week-on-week rise is a modest 3.7%, suggesting the aggressive short rebuild has run most of its course rather than accelerating into a new wave.
The borrow market reinforces that read. Availability has eased dramatically from the tight conditions seen in late July, when it dipped below 93% — close to the point where lenders were running out of shares to place. It now reads at 297%, meaning roughly three shares are available to lend for every one currently borrowed. Cost to borrow ticked up 18% on the week to 0.58%, its highest level in recent days, but in absolute terms remains negligible — barely above overnight financing rates. There is no squeeze pressure here. Shorts rebuilding into a loose lending market signals a considered tactical view on industrials, not a forced or squeezed position.
Options positioning has softened from its most defensive stance. The put/call ratio eased to 2.84, slightly below its 20-day mean of 2.93 — a z-score of -0.45, meaning the ratio is roughly half a standard deviation below average. That is a meaningful contrast to July, when the PCR was regularly printing above 3.1 and peaked near 3.2. The 52-week range runs from 2.01 to 5.54, so the current reading sits toward the lower end of the recent distribution, pointing to options hedging that has dialled back relative to the past month. Taken together with the stalled short rebuild, the overall positioning tone has shifted from actively cautious to something more neutral.
The ORTEX short score has drifted lower this week, from 63.1 on August 6 — the highest reading in the recent window — to 57.9, closer to where it spent most of July. That score peaked on the same day availability was tightest and the PCR was elevated, suggesting a brief alignment of bearish signals that has since partially unwound. The score sitting in the high 50s rather than the 60s reflects a market that has moderated its short-side conviction without abandoning it.
On the institutional side, JPMorgan trimmed its position by roughly 999,000 shares in Q2, while Phoenix Investments and Fisher Asset Management each added meaningfully — 1.4 million and 886,000 shares respectively. The net picture among the top holders is mixed rather than directionally clear, consistent with the broader positioning ambiguity the data describes.
The week ahead is less about a specific catalyst — XLI carries no earnings event — and more about whether the plateau in short interest holds, or whether fresh macro data on manufacturing activity and construction spending pushes shorts to add or cover from here.
See the live data behind this article on ORTEX.
Open XLI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
